Essex Investment Management’s Endologix Inc ELGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
Sell
-5,163
Closed -$661K 394
2016
Q3
$661K Buy
5,163
+1,738
+51% +$222K 0.11% 223
2016
Q2
$427K Buy
+3,425
New +$394K 0.07% 256
2015
Q2
Sell
-3,964
Closed -$677K 352
2015
Q1
$677K Buy
3,964
+1,934
+95% +$293K 0.09% 211
2014
Q4
$310K Hold
2,030
0.05% 276
2014
Q3
$215K Sell
2,030
-6,535
-76% -$911K 0.03% 323
2014
Q2
$1.3M Sell
8,565
-1,343
-14% -$179K 0.19% 146
2014
Q1
$1.27M Buy
9,908
+453
+5% +$70.4K 0.19% 168
2013
Q4
$1.65M Buy
9,455
+288
+3% +$49.5K 0.23% 127
2013
Q3
$1.48M Buy
9,167
+7,882
+613% +$1.24M 0.22% 125
2013
Q2
$171K Buy
+1,285
New +$181K 0.03% 321

Other funds holding ELGX

Essex Investment Management's ELGX Position: Q4 2016 in Review

Essex Investment Management sold out of Endologix Inc (ELGX) in Q4 2016, closing a stake of 5,163 shares — an estimated $661K sold.

Essex Investment Management first reported a position in ELGX in Q2 2013 and held it in 10 quarters. The position peaked at $1.65M in Q4 2013. 140 funds tracked by Wall St. Rank hold ELGX as of Q4 2016.

  • Essex Investment Management reported no remaining Endologix Inc position as of Q4 2016 after selling out during the quarter.
  • Essex Investment Management sold 5,163 Endologix Inc shares in Q4 2016, an estimated $661K.
  • Essex Investment Management first reported a position in Endologix Inc in Q2 2013 and held it in 10 quarters.
  • Essex Investment Management's Endologix Inc position peaked at $1.65M in Q4 2013.
  • 140 funds tracked by Wall St. Rank held Endologix Inc as of Q4 2016.

Based on Essex Investment Management's 13F filing for Q4 2016, filed 8 Feb 2017.